Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy
- PMID: 39612916
- PMCID: PMC11896817
- DOI: 10.1016/j.immuni.2024.11.002
Cognate antigen engagement induces HIV-1 expression in latently infected CD4+ T cells from people on long-term antiretroviral therapy
Abstract
Despite antiretroviral therapy (ART), HIV-1 persists in latently infected CD4+ T cells, preventing a cure. Antigens drive the proliferation of infected cells, precluding latent reservoir decay. However, the relationship between antigen recognition and HIV-1 gene expression is poorly understood because most studies of latency reversal use agents that induce non-specific global T cell activation. Here, we isolated rare CD4+ T cells responding to cytomegalovirus (CMV) or HIV-1 Gag antigens from people living with HIV-1 on long-term ART and assessed T cell activation and HIV-1 RNA expression upon coculture with autologous dendritic cells (DCs) presenting cognate antigens. Presentation of cognate antigens ex vivo induced broad T cell activation (median 42-fold increase in CD154+CD69+ cells) and significantly increased HIV-1 transcription (median 4-fold), mostly through the induction of rare cells with higher viral expression. Thus, despite low proviral inducibility, antigen recognition can promote HIV-1 expression, potentially contributing to spontaneous reservoir activity and viral rebound upon ART interruption.
Keywords: CD4(+) T cells; HIV-1 latent reservoir; HIV-1 persistence; antigenic stimulation; cytomegalovirus; dendritic cells; latency reversal.
Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests R.F.S. is one of the inventors of a patent application involving aspects of the IPDA entitled “Compositions and methods Related to characterizing proviral reservoirs,” PCT/US16/28822, filed by Johns Hopkins University. F.R.S. received payments from Gilead Sciences for participating at scientific meetings. F.W. is currently an employee of Gilead Sciences. N.L.B. is currently a postdoctoral associate in medicine at Weill Cornell Medical College.
Similar articles
-
Type 1-programmed dendritic cells drive antigen-specific latency reversal and immune elimination of persistent HIV-1.EBioMedicine. 2019 May;43:295-306. doi: 10.1016/j.ebiom.2019.03.077. Epub 2019 Apr 2. EBioMedicine. 2019. PMID: 30952614 Free PMC article.
-
Maraviroc Is Associated with Latent HIV-1 Reactivation through NF-κB Activation in Resting CD4+ T Cells from HIV-Infected Individuals on Suppressive Antiretroviral Therapy.J Virol. 2018 Apr 13;92(9):e01931-17. doi: 10.1128/JVI.01931-17. Print 2018 May 1. J Virol. 2018. PMID: 29444937 Free PMC article.
-
TLR1/2 Agonist Enhances Reversal of HIV-1 Latency and Promotes NK Cell-Induced Suppression of HIV-1-Infected Autologous CD4+ T Cells.J Virol. 2021 Aug 10;95(17):e0081621. doi: 10.1128/JVI.00816-21. Epub 2021 Aug 10. J Virol. 2021. PMID: 34133900 Free PMC article.
-
Role of Dendritic Cells in Exposing Latent HIV-1 for the Kill.Viruses. 2019 Dec 28;12(1):37. doi: 10.3390/v12010037. Viruses. 2019. PMID: 31905690 Free PMC article. Review.
-
Low Inducibility of Latent Human Immunodeficiency Virus Type 1 Proviruses as a Major Barrier to Cure.J Infect Dis. 2021 Feb 15;223(12 Suppl 2):13-21. doi: 10.1093/infdis/jiaa649. J Infect Dis. 2021. PMID: 33586775 Free PMC article. Review.
Cited by
-
HIV-1 Rebound Virus Consists of a Small Number of Lineages That Entered the Reservoir Close to ART Initiation.bioRxiv [Preprint]. 2025 Jan 31:2025.01.29.635391. doi: 10.1101/2025.01.29.635391. bioRxiv. 2025. PMID: 39975202 Free PMC article. Preprint.
-
FUBP3: A new player in HIV-1 transcriptional activation and immune regulation.Mol Ther Nucleic Acids. 2025 May 27;36(2):102565. doi: 10.1016/j.omtn.2025.102565. eCollection 2025 Jun 10. Mol Ther Nucleic Acids. 2025. PMID: 40510595 Free PMC article. No abstract available.
-
Applications and limitations of the passenger hypothesis for HIV reservoir persistence and cure.J Virol. 2025 Jul 22;99(7):e0071425. doi: 10.1128/jvi.00714-25. Epub 2025 Jun 4. J Virol. 2025. PMID: 40464563 Free PMC article. Review.
References
-
- Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, Chaisson RE, Quinn TC, Chadwick K, Margolick J, Brookmeyer R, et al. (1997). Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science (1979) 278, 1295–1300. 10.1126/science.278.5341.1295. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials